Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by John Laffey and Daniel McAuley.
John Laffey
Connection Strength
0.918
Daniel McAuley
  1. Emerging pharmacological therapies for ARDS: COVID-19 and beyond. Intensive Care Med. 2020 12; 46(12):2265-2283.
    View in: PubMed
    Score: 0.223
  2. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Trials. 2020 Jun 03; 21(1):462.
    View in: PubMed
    Score: 0.221
  3. Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2018 01; 44(1):157-165.
    View in: PubMed
    Score: 0.187
  4. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017 08; 5(8):627-638.
    View in: PubMed
    Score: 0.180
  5. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
    View in: PubMed
    Score: 0.057
  6. Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database. Crit Care. 2018 10 27; 22(1):268.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.